Hernan Funes-Cortes
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Topical heparin as an effective and safe treatment for patients with capecitabine-induced hand-foot syndrome: results of a phase IIA trial supported by proteomic profiling of skin biopsies.
Journal: Therapeutic advances in medical oncology
Published: September 20, 2021
Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study.
Journal: Anticancer research
Published: December 06, 2015
Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 14, 2014
Erythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience.
Journal: Journal of blood medicine
Published: May 24, 2014
Risk factors associated with Clostridium difficile infection in adult oncology patients.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: May 22, 2014
Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer.
Journal: Journal of cancer research and clinical oncology
Published: May 13, 2014
Prognostic value of dual-specificity phosphatase 6 expression in non-small cell lung cancer.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: March 27, 2014
A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trial.
Journal: Breast (Edinburgh, Scotland)
Published: February 24, 2014
Clinical experience with plerixafor as a mobilization regimen for autologous peripheral blood stem cell transplantation in patients with refractory germ cell tumors.
Journal: Molecular and clinical oncology
Published: December 04, 2013
The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: September 16, 2013
Role of inhibitors of mammalian target of rapamycin in the treatment of luminal breast cancer.
Journal: Anti-cancer drugs
Published: July 11, 2013
Last Updated: 09/26/2026